NCT01356550View on ClinicalTrials.gov

A Study on The Effect of Hepatic Impairment on The Pharmacokinetics of RO4917838

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Healthy Volunteer
Interventions
DRUG

RO4917838

single oral dose

Trial Locations (3)

35042

Rennes

117192

Moscow

117292

Moscow

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01356550 - A Study on The Effect of Hepatic Impairment on The Pharmacokinetics of RO4917838 | Biotech Hunter | Biotech Hunter